• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新的和更新的治疗幼年特发性关节炎相关葡萄膜炎和特发性慢性前葡萄膜炎的建议。

New and Updated Recommendations for the Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis and Idiopathic Chronic Anterior Uveitis.

机构信息

Schön Klinik Hamburg Eilbek, Hamburg, Germany.

Meyer Children's Hospital, University of Florence, Florence, Italy.

出版信息

Arthritis Care Res (Hoboken). 2023 May;75(5):975-982. doi: 10.1002/acr.24963. Epub 2023 Jan 10.

DOI:10.1002/acr.24963
PMID:35638697
Abstract

OBJECTIVE

The Multinational Interdisciplinary Working Group for Uveitis in Childhood identified the need to update the current guidelines, and the objective here was to produce this document to guide clinicians managing children with juvenile idiopathic arthritis-associated uveitis (JIAU) and idiopathic chronic anterior uveitis (CAU).

METHODS

The group analyzed the literature published between December 2014 and June 2020 after a systematic literature review conducted by 2 clinicians. Pediatric rheumatologists were paired with ophthalmologists to review the eligible 37 publications. The search criteria were selected to reflect those used for the 2018 Single Hub and Access point for pediatric Rheumatology in Europe (SHARE) recommendations, in order to provide an update, rather than a replacement for that publication. The summary of the current evidence for each SHARE recommendation was presented to the expert committee. These recommendations were then discussed and revised during a video consensus meeting on January 22, 2021, with 14 voting participants, using a nominal group technique to reach consensus.

RESULTS

JIAU treatment was extended to include CAU. Fourteen recommendations regarding treatment of JIAU und CAU with >90% agreement were accepted.

CONCLUSION

An update to the previous 2018 SHARE recommendations for the treatment of children with JIAU with the addition of CAU was created using an evidence-based consensus process. This guideline should help support clinicians to care for children and young people with CAU.

摘要

目的

多国儿科学多学科工作组(Multinational Interdisciplinary Working Group for Uveitis in Childhood)确定需要更新当前的指南,本研究的目的是制定本文件,以指导管理儿童幼年特发性关节炎相关葡萄膜炎(juvenile idiopathic arthritis-associated uveitis,JIAU)和特发性慢性前葡萄膜炎(idiopathic chronic anterior uveitis,CAU)的临床医生。

方法

该工作组对 2 位临床医生进行系统文献回顾后,于 2014 年 12 月至 2020 年 6 月期间对文献进行了分析。小儿风湿病专家与眼科医生合作,对 37 篇符合条件的文献进行了审查。该搜索标准的选择反映了 2018 年欧洲儿科风湿病单一枢纽和接入点(Single Hub and Access point for pediatric Rheumatology in Europe,SHARE)建议中使用的标准,以便提供更新,而不是替代该出版物。每位专家委员会成员都提交了当前证据摘要,以用于 SHARE 推荐。2021 年 1 月 22 日,通过视频共识会议讨论和修订了这些建议,14 名有投票权的参与者使用名义小组技术达成共识。

结果

将 JIAU 的治疗方法扩展到 CAU。接受了 14 项针对 JIAU 和 CAU 治疗的建议,这些建议获得了超过 90%的共识。

结论

使用循证共识过程更新了 2018 年 SHARE 推荐治疗 JIAU 儿童的指南,增加了 CAU。该指南应有助于支持临床医生为 CAU 患儿和青少年提供护理。

相似文献

1
New and Updated Recommendations for the Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis and Idiopathic Chronic Anterior Uveitis.新的和更新的治疗幼年特发性关节炎相关葡萄膜炎和特发性慢性前葡萄膜炎的建议。
Arthritis Care Res (Hoboken). 2023 May;75(5):975-982. doi: 10.1002/acr.24963. Epub 2023 Jan 10.
2
Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans for Juvenile Idiopathic Arthritis-Associated and Idiopathic Chronic Anterior Uveitis.儿童关节炎和风湿病研究联盟共识治疗方案:青少年特发性关节炎相关和特发性慢性前葡萄膜炎。
Arthritis Care Res (Hoboken). 2019 Apr;71(4):482-491. doi: 10.1002/acr.23610.
3
Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative.基于共识的幼年特发性关节炎相关葡萄膜炎管理推荐:SHARE 倡议。
Ann Rheum Dis. 2018 Aug;77(8):1107-1117. doi: 10.1136/annrheumdis-2018-213131. Epub 2018 Mar 28.
4
Recommendations for the Management of Uveitis Associated With Juvenile Idiopathic Arthritis: The Czech and Slovak adaptation of SHARE Initiative.青少年特发性关节炎相关葡萄膜炎管理建议:SHARE倡议的捷克和斯洛伐克版本
Cesk Slov Oftalmol. 2020 Fall;76(4):1-15. doi: 10.31348/2020/7.
5
Update of the evidence based, interdisciplinary guideline for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis.更新基于循证、跨学科的指南:用于治疗与幼年特发性关节炎相关的葡萄膜炎的抗炎治疗。
Semin Arthritis Rheum. 2019 Aug;49(1):43-55. doi: 10.1016/j.semarthrit.2018.11.004. Epub 2018 Dec 4.
6
Canadian Rheumatology Association Recommendations for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis.加拿大风湿病学会关于幼年特发性关节炎相关葡萄膜炎的筛查、监测和治疗建议。
J Rheumatol. 2023 Mar;50(3):390-399. doi: 10.3899/jrheum.220261. Epub 2022 Oct 15.
7
Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC).基于多国儿童期葡萄膜炎协作组(MIWGUC)验证的与葡萄膜炎相关的幼年特发性关节炎(JIA)结局指标,提出 JIA 相关葡萄膜炎的治疗反应、疾病不活动和损伤定义的建议。
Pediatr Rheumatol Online J. 2019 Oct 1;17(1):66. doi: 10.1186/s12969-019-0345-2.
8
Recommendations for the management of childhood juvenile idiopathic arthritis-type chronic anterior uveitis.儿童幼年特发性关节炎型慢性前葡萄膜炎管理建议。
Clin Exp Ophthalmol. 2021 Jan;49(1):38-45. doi: 10.1111/ceo.13856. Epub 2021 Jan 10.
9
How should we approach management of childhood onset chronic anterior uveitis refractory to adalimumab?对于儿童发病的慢性前葡萄膜炎,阿达木单抗治疗无效时应如何治疗?
Expert Rev Clin Immunol. 2024 Mar;20(3):267-276. doi: 10.1080/1744666X.2023.2284845. Epub 2023 Nov 28.
10
Arthritis and uveitis in children. A pediatric rheumatology perspective.儿童关节炎与葡萄膜炎。儿科风湿病学视角。
Am J Ophthalmol. 2003 Jun;135(6):879-84. doi: 10.1016/s0002-9394(03)00104-1.

引用本文的文献

1
Uveitis associated with juvenile idiopathic arthritis and chronic idiopathic uveitis in children: A retrospective cohort study.儿童青少年特发性关节炎相关葡萄膜炎和慢性特发性葡萄膜炎:一项回顾性队列研究。
World J Clin Pediatr. 2025 Jun 9;14(2):100336. doi: 10.5409/wjcp.v14.i2.100336.
2
Metabolomics of ocular immune diseases.眼部免疫疾病的代谢组学
Metabolomics. 2025 Jun 2;21(3):74. doi: 10.1007/s11306-025-02273-9.
3
Treatment outcomes of a Swiss non-infectious paediatric uveitis cohort: retrospective study over ten years.瑞士非感染性儿童葡萄膜炎队列的治疗结果:十年回顾性研究
J Ophthalmic Inflamm Infect. 2025 May 8;15(1):43. doi: 10.1186/s12348-025-00458-w.
4
Juvenile idiopathic arthritis and associated uveitis: A review of pathogenesis, diagnosis, and management.青少年特发性关节炎及相关葡萄膜炎:发病机制、诊断与管理综述
Saudi J Ophthalmol. 2025 Jan 2;39(1):31-40. doi: 10.4103/sjopt.sjopt_153_24. eCollection 2025 Jan-Mar.
5
Recurrence Risk in Pediatric Noninfectious Uveitis During Adalimumab Tapering: An International Multicenter Retrospective Study.阿达木单抗减量期间儿童非感染性葡萄膜炎的复发风险:一项国际多中心回顾性研究
Arthritis Rheumatol. 2025 Sep;77(9):1254-1262. doi: 10.1002/art.43165. Epub 2025 May 13.
6
Reducing the risk of visual disability for children with juvenile idiopathic arthritis uveitis through disease surveillance: past and future challenges.通过疾病监测降低青少年特发性关节炎葡萄膜炎患儿视力残疾风险:过去与未来的挑战
Pediatr Rheumatol Online J. 2025 Jan 20;23(1):4. doi: 10.1186/s12969-024-01037-4.
7
Implementation study of the CARRA Uveitis Consensus Treatment Plans: feasibility for clinical practice and applicability for research.CARRA 葡萄膜炎共识治疗方案的实施研究:临床实践的可行性和研究的适用性。
Pediatr Rheumatol Online J. 2024 Oct 7;22(1):88. doi: 10.1186/s12969-024-01022-x.
8
Rituximab in the Treatment of Non-Infectious Uveitis: A Review.利妥昔单抗治疗非感染性葡萄膜炎:综述
J Inflamm Res. 2024 Sep 29;17:6765-6780. doi: 10.2147/JIR.S477708. eCollection 2024.
9
To switch or to swap? Evidence from a meta-analysis for the best treatment approach in childhood chronic uveitis resistant to the I anti-TNF.切换还是互换?一项关于儿童慢性葡萄膜炎抗TNF治疗耐药的最佳治疗方法的荟萃分析证据
J Transl Autoimmun. 2024 Jun 22;9:100247. doi: 10.1016/j.jtauto.2024.100247. eCollection 2024 Dec.
10
Establishing the Normative Data Set Necessary for Imaging-Based Childhood Uveitis Surveillance: A Cross-Sectional Study.建立基于影像学的儿童葡萄膜炎监测的规范数据集:一项横断面研究。
Invest Ophthalmol Vis Sci. 2024 Jan 2;65(1):9. doi: 10.1167/iovs.65.1.9.